Denali therapeutics dnli
WebDec 5, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to ... WebApr 7, 2024 · Denali Therapeutics Inc’s trailing 12-month revenue is $108.5 million with a -300.6% profit margin. Year-over-year quarterly sales growth most recently was -17.6%. …
Denali therapeutics dnli
Did you know?
WebApr 13, 2024 · Denali Therapeutics (DNLI) In a report released yesterday, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics, with a price target of $50.00. The company’s shares closed ... Web1 day ago · In the last 3 months, 9 analysts have offered 12-month price targets for Denali Therapeutics. The company has an average price target of $67.44 with a high of $105.00 and a low of $38.00.
WebAbout Denali Therapeutics Inc. 161 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, California, 94080, United States +1 650 866-8548 … WebMar 31, 2024 · As of March 31, 2024, 4:00 PM CST, Denali Therapeutics Inc’s stock price was $23.04. Denali Therapeutics Inc is up 5.16% from its previous closing price of $21.91. During the last market session, Denali Therapeutics Inc’s stock traded between $21.74 and $23.54. Currently, there are 132.96 million shares of Denali Therapeutics Inc stock ...
WebAs of April 6, 2024, the average one-year price target for Denali Therapeutics is $60.88. The forecasts range from a low of $32.32 to a high of $110.25. The average price target … WebCompany profile page for Denali Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
WebApr 14, 2024 · Denali Therapeutics (NASDAQ:DNLI – Get Rating) had its target price hoisted by analysts at Morgan Stanley from $61.00 to $63.00 in a report released on …
Web1 day ago · In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Denali Therapeutics ( DNLI – Research Report ), with a price target of $54.00. The company’s ... buy crystal glasses onlineWebJan 31, 2024 · Denali Therapeutics Inc. ClinicalTrials.gov Identifier: NCT04251026 Other Study ID Numbers: DNLI-E-0002 2024-004909-27 ( EudraCT Number ) First Posted: January 31, 2024 Key Record Dates: Last Update Posted: November 17, 2024 Last Verified: November 2024 Individual Participant Data (IPD) Sharing Statement: cell phone operator numberWebMar 17, 2024 · Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for … buy crystal cleanWebApr 13, 2024 · DNLI stock opened at $24.13 on Wednesday. Denali Therapeutics has a 1-year low of $20.24 and a 1-year high of $39.43. The company has a market capitalization … cell phone opinion writingWebJul 26, 2024 · Shares of Denali Therapeutics ( DNLI 0.36%) had sunk 11.2% as of 12:02 p.m. EDT on Monday. The decline came after the company presented interim results on Sunday from a phase 1/2 study evaluating ... buy crystal clear plastic containersWebDenali Therapeutics (DNLI) Gets a Buy from Morgan Stanley March 1, 2024TipRanks. Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), … buy crystal head vodka onlineWeb1 day ago · In the last 3 months, 9 analysts have offered 12-month price targets for Denali Therapeutics. The company has an average price target of $67.44 with a high of $105.00 and a low of $38.00. buy crystal healing bed